Liam Ratcliffe
Affiliations
- Director at Arvinas Inc. (ARVN), 2022-06-22
- Director at Eliem Therapeutics Inc. (ELYM), 2022-06-01
- Director at Passage Bio Inc. (PASG), 2021-05-28
- Director at Unum Therapeutics Inc. (UMRX), 2019-06-18
- Director at Aptinyx Inc. (APTX), 2019-04-02
- Director at Edge Therapeutics Inc. (EDGE), 2019-03-18
- Large Shareholder at Iterum Therapeutics Plc (ITRM), 2018-05-31
- Large Shareholder, Director at Deciphera Pharmaceuticals Inc. (DCPH), 2018-05-21
- Large Shareholder at Irhythm Technologies Inc. (IRTC), 2016-10-25
- Large Shareholder at Mei Pharma Inc. (MEIP), 2015-03-26
- Large Shareholder at Versartis Inc. (VSAR), 2014-12-22
- Large Shareholder at Durata Therapeutics Inc. (DRTX), 2014-11-18
- Large Shareholder at Chimerix Inc (CMRX), 2014-03-20
- Large Shareholder at Concert Pharmaceuticals Inc. (CNCE), 2014-02-21
- Other at Oxford Immunotec Global Plc (OXFD), 2013-12-03
- Other at Relypsa Inc (RLYP), 2013-11-21
- Director at Array Biopharma Inc (ARRY), 2013-10-25
Insider Trading: Purchases See All
| Company | Symbol | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|---|
| ARVN | $70.00 | 142,857 | Director | 822,857 | 2020-12-18 | Filing | |
| PASG | $18.00 | 2,800 | Director | 2,800 | 2020-03-03 | Filing | |
| PASG | $18.00 | 550,000 | Director | 2,616,630 | 2020-03-03 | Filing | |
| PASG | $18.00 | 2,800 | Director | 2,800 | 2020-03-03 | Filing | |
| ARVN | $22.00 | 680,000 | Director | 680,000 | 2019-11-12 | Filing |
Insider Trading: Sales See All
| Company | Symbol | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|---|
| ARVN | $68.97 | 37,206 | Director | 185,686 | 2021-12-16 | Filing | |
| ARVN | $69.66 | 48,499 | Director | 222,892 | 2021-12-16 | Filing | |
| ARVN | $65.74 | 5,695 | Director | 271,391 | 2021-12-15 | Filing | |
| ARVN | $66.50 | 67,549 | Director | 277,086 | 2021-12-15 | Filing | |
| ARVN | $67.46 | 40,292 | Director | 344,635 | 2021-12-15 | Filing |